Evidence map›Paper›PMID 36635505›Full record

ArticleNature cell biology2023

Polycomb repressive complexes 1 and 2 are each essential for maintenance of X inactivation in extra-embryonic lineages.

Osamu Masui, Catherine Corbel, Koji Nagao, Takaho A Endo, Fuyuko Kezuka, Patricia Diabangouaya, Manabu Nakayama, Mami Kumon, Yoko Koseki, Chikashi Obuse and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Epigenetic remodeling during early embryonic development.Frontiers in cell and developmental biology · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Polycomb function in early mouse development.Cell death and differentiation · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Osamu Masui *Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Catherine Corbel *Unité de Génétique et Biologie du Développement, Institut Curie, PSL Research University, CNRS UMR 3215, INSERM U934, Paris, France.
Koji NagaoDepartment of Biological Sciences, Graduate School of Science, Osaka University, Toyonaka, Japan.ORCID 0000-0003-1418-6988
Takaho A EndoLaboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID 0000-0002-2801-2463
Fuyuko KezukaLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Patricia DiabangouayaUnité de Génétique et Biologie du Développement, Institut Curie, PSL Research University, CNRS UMR 3215, INSERM U934, Paris, France.
Manabu NakayamaLaboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Japan.
Mami KumonLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Yoko KosekiLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Chikashi ObuseDepartment of Biological Sciences, Graduate School of Science, Osaka University, Toyonaka, Japan.
Haruhiko KosekiLaboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. haruhiko.koseki@riken.jp.ORCID 0000-0001-8424-5854
Edith HeardUnité de Génétique et Biologie du Développement, Institut Curie, PSL Research University, CNRS UMR 3215, INSERM U934, Paris, France. edith.heard@embl.org.ORCID 0000-0001-8052-7117
RIKEN Center for Integrative Medical Sciences · JPCentre National de la Recherche Scientifique · FRChiba University · JPThe University of Osaka · JPKazusa DNA Research Institute · JP

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ANR-11-LABX-0044European Research Council 671027MEXT | Japan Science and Technology Agency (JST) 17H06426MEXT | JST | Core Research for Evolutional Science and Technology (CREST) 13417643MEXT | JST | Precursory Research for Embryonic Science and Technology (PRESTO) JPMJPR11SE
6 · The paper itself

Abstract

In female mammals, one of the two X chromosomes becomes inactivated during development by X-chromosome inactivation (XCI). Although Polycomb repressive complex (PRC) 1 and PRC2 have both been implicated in gene silencing, their exact roles in XCI during in vivo development have remained elusive. To this end, we have studied mouse embryos lacking either PRC1 or PRC2. Here we demonstrate that the loss of either PRC has a substantial impact on maintenance of gene silencing on the inactive X chromosome (Xi) in extra-embryonic tissues, with overlapping yet different genes affected, indicating potentially independent roles of the two complexes. Importantly, a lack of PRC1 does not affect PRC2/H3K27me3 accumulation and a lack of PRC2 does not impact PRC1/H2AK119ub1 accumulation on the Xi. Thus PRC1 and PRC2 contribute independently to the maintenance of XCI in early post-implantation extra-embryonic lineages, revealing that both Polycomb complexes can be directly involved and differently deployed in XCI.

Indexed as

Polycomb Repressive Complex 1X Chromosome InactivationAnimalsFemaleMammalsMicePolycomb-Group ProteinsPolycomb Repressive Complex 2X ChromosomePolycomb-Group ProteinsPolycomb Repressive Complex 1Polycomb Repressive Complex 2

Identifiers

PMID36635505
PMCPMC7616894
OpenAlexW4315784633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.